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Abstract
During mouse embryogenesis, proper formation of the heart and liver is especially important and is crucial for embryonic
viability. In this study, we showed that Mab21l2 was expressed in the trabecular and compact myocardium, and that
deletion of Mab21l2 resulted in a reduction of the trabecular myocardium and thinning of the compact myocardium.
Mab21l2-deficient embryonic hearts had decreased expression of genes that regulate cell proliferation and apoptosis of
cardiomyocytes. These results show that Mab21l2 functions during heart development by regulating the expression of such
genes. Mab21l2 was also expressed in the septum transversum mesenchyme (STM). Epicardial progenitor cells are localized
to the anterior surface of the STM (proepicardium), and proepicardial cells migrate onto the surface of the heart and form
the epicardium, which plays an important role in heart development. The rest of the STM is essential for the growth and
survival of hepatoblasts, which are bipotential progenitors for hepatocytes and cholangiocytes. Proepicardial cells in
Mab21l2-deficient embryos had defects in cell proliferation, which led to a small proepicardium, in which a4 integrin
expression, which is essential for the migration of proepicardial cells, was down-regulated, suggesting that defects occurred
in its migration. In Mab21l2-deficient embryos, epicardial formation was defective, suggesting that Mab21l2 plays important
roles in epicardial formation through the regulation of the cell proliferation of proepicardial cells and the migratory process
of proepicardial cells. Mab21l2-deficient embryos also exhibited hypoplasia of the STM surrounding hepatoblasts and
decreased hepatoblast proliferation with a resultant loss of defective morphogenesis of the liver. These findings
demonstrate that Mab21l2 plays a crucial role in both heart and liver development through STM formation.
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Introduction
Two distinct heart fields, the FHF (first heart field) and the SHF
(second heart field), are derived from anterior lateral plate
mesoderm and splanchnic mesoderm, respectively. In the mouse
embryo, the FHF forms a crescent shape at E7.5, and the cells
coalesce along the ventral midline to form an early heart tube at
E8.0. At this stage, the SHF begins to migrate to the anterior and
posterior ends of the heart tube to form the right ventricle,
conotruncus and part of the atria. The heart tube then undergoes a
process involving rightward looping and expansion of the
myocardium, leading to the formation of the four-chambered heart
[1,2]. Ventricular myocardial differentiation and maturation are
characterized by the formation of both the compact myocardium
and the trabecular myocardium. The compact myocardium forms
in the outer zone of the ventricular wall and trabecular myocardium
forms as protrusions along the inside of the compact myocardium
[3]. Proper development of the compact and the trabecular
myocardium is required for normal contractility and circulation of
blood, and the importance of the appropriate development of these
structures is demonstrated by the fact that deletion of genes essential
for the normal development of these structures causes embryonic
lethality at approximately midgestation.
Mammalian liver development begins with hepatic induction
from the ventral endoderm through signaling molecules such as
FGFs and BMPs, derived from the cardiac mesoderm and septum
transversum mesenchyme (STM), respectively. After specification
of the hepatic endoderm, the tissue starts extending towards the
midgut. Following formation of the liver bud, the basement
membrane surrounding it is progressively disrupted, and hepato-
blasts (bipotential progenitors for hepatocytes and cholangiocytes)
delaminate from the bud and invade the surrounding STM as
cords. At this stage, the STM functions as a source of signals for
hepatoblast growth and survival, and inactivation of genes
encoding those signaling molecules causes liver hypoplasia
(reviewed in [4,5]).
The STM is required not only for liver development but also for
heart development in forming the proepicardium. The proepi-
cardium is a region of the STM caudal to the heart, and cells in
this mesenchymal structure spread over the surface of the
myocardium to form the epicardium, the epithelial outer layer
of the heart [6,7]. Epicardial cells undergo an epithelial-to-
mesenchymal transition, penetrate into the neighboring myocar-
dium and differentiate into the cells required for cardiovascular
development, such as myofibroblast, pericytes, and smooth muscle
cell [8,9,10,11]. Epicardial cells are important not only as a source
of cells contributing to heart development, but also as a source of
signaling molecules regulating proliferation of the myocardium.
Signaling molecules including erythropoietin, retinoic acid and
FGF are produced in the epicardium, and communication
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is required for normal myocardial proliferation [12,13]. Therefore,
the STM is an important tissue involved in both heart and liver
development.
The mab-21 gene was originally identified as a cell fate
determinant in Caenorhabditis elegans and several studies have shown
that mab-21 is highly conserved across animal species, from
vertebrates to invertebrates [14,15,16]. Two mab-21 orthologues,
Mab21l1 and Mab21l2, havebeenfound inspecies such as zebrafish,
Xenopus, chicken, mouse, and human [14,16,17,18,19,20]. MAB-
21 family proteins in vertebrates have more than 90% amino acid
sequence similarity, but do not have any known functional motifs.
Thus predicting the molecular functions of MAB-21 proteins from
their amino acid sequence is difficult. Several studies in vertebrates
have shown that Mab21l1 and Mab21l2 expression overlap in the
eye, midbrain, branchial arches, and limb buds during develop-
ment. In mouse, Mab21l1 is uniquely expressed in the lens and
genital tubercle while Mab21l2 expression is found in the retina,
body wall and umbilical cord [14,16,19,20,21,22].
We have previously shown that Mab21l1-deficient mice have
defects in eye and preputial gland development, and that
MAB21L1 functions cell-autonomously in the lens. Additionally,
Mab21l2-deficient mice, which are embryonic lethal between
E11.5 and E14.5 (lethality rate of homozygous mutant embryos:
E11.5, 14%; E12.5, 65%; E13.5, 64%), have defects in eye and
body wall formation. Thus, Mab21l1 and Mab21l2 function during
eye development; Mab21l1 is essential for lens placode develop-
ment and Mab21l2 is essential for retina development. Mab21l1
and Mab21l2 are thought to function downstream of Pax6 in eye
development [21,23]. Mab21l1 is also essential for the appropriate
development of the preputial glands, while Mab21l2 plays a crucial
role in ventral body wall formation [21,22].
We analyzed in detail, the expression of Mab21l2 and
embryonic tissues of Mab21l2-deficient mice. Mab21l2 begins to
be expressed in the heart region at approximately E8.5, and is
expressed in both the trabecular and the compact myocardium at
E9.5–E11.5, and deletion of Mab21l2 results in a reduction in the
amount of trabecular myocardium and a thinning of the compact
myocardium. BrdU and TUNEL assays demonstrated that cell
proliferation decreased and apoptosis increased in Mab21l2
mutants. The Mab21l2 transcript is also found in the STM from
the region of the proepicardium to the region near the
hepatoblasts at E9.5, and Mab21l2 deletion causes defective
morphogenesis of that tissue and results in defects in the
epicardium and liver, demonstrating that Mab21l2 is essential for
heart and liver development through the STM. Taken together,
these results indicate that Mab21l2 is expressed in the cardiac field
and the STM and plays essential roles during heart and liver
development.
Results
Mab21l2 is expressed in the trabecular and compact
myocardium and is required for normal development of
these tissues
Embryonic lethality in Mab21l2-deficient embryos first occurred
at approximately E11.5. Living embryos were observed until
E13.5 [22], but in E13.5 Mab21l2 mutant embryos, the heartbeat
was very weak. A known defect which results in embryonic
lethality at around E11.5 is defective morphogenesis of the heart
and cardiovascular system. Therefore, we examined whether the
expression of Mab21l2 was detected in those tissues before E11.5 in
wild-type embryos by in situ hybridization. At the 2-somite stage,
Mab21l2 appeared to be expressed adjacent to the first heart field
(identified by Nkx2.5 expression, the first heart field marker), i.e.
the presumptive STM [24] (Figure 1A, B). At E8.5, the expression
of Mab21l2 was detected in the ventricle and sinus venosus
myocardium (Figure 1C, D). At E9.5, Mab21l2 was expressed in
the STM (Figure 1E, F) and the ventricular myocardium, in both
the trabecular and the compact myocardium (Figure 1G, S1A, B;
Nkx2.5, myocardial marker). Especially, the expression was
detected in the future right ventricle and left ventricle (Figure 1H
black arrowheads). At E10.5 and E11.5, the expression of Mab21l2
was largely detected in the myocardium of the left ventricle,
especially in the left side of the structures. The expression was
strongest in the region between the atrium and ventricle
(Figure 1I–L). At E12.5, the expression of Mab21l2 was only
detectable at low levels in the trabecular region of the left ventricle
(Figure S2A, B). The expression of Mab21l1, another mab-21
orthologue, was not detected in the heart region.
To study the contribution of Mab21l2 expression to heart
development, we examined hematoxylin and eosin (H&E) stained
sections of Mab21l2-deficient embryos, and found defects in the
heart region. In some Mab21l2 embryos (3/32 embryos) at E10.5,
the compact myocardium of the left ventricle was thinner (Figure
S3H, J) than in wild-type embryos (Figure S3G, I) and at E11.5, in
addition to the thin layer of compact myocardium, Mab21l2-
deficient embryos had a reduced trabecular myocardium in the left
ventricle (Figure 1R) compared to wild-type embryos (Figure 1O),
although defects were not grossly observed in the right ventricle of
Mab21l2-deficient embryos (Figure 1Q) when they were compared
to wild-type embryos (Figure 1N) (After E11.5, defects in the heart
region were observed in all Mab21l2-deficient embryos.). At E12.5,
defects in the compact and trabecular myocardium were observed
not only in the left, but also in the right ventricle of Mab21l2-
deficient embryos (Figure 1W, X). Defective morphogenesis of the
atrium was not observed in Mab21l2-deficient embryos at E10.5–
E12.5 (Figure S3H, 1P, V). No defects in the heart region,
including the endocardium and myocardium, were observed at
E8.5 (Figure S3A, B) or E9.5 (Figure S3C–F). These results
demonstrate that Mab21l2 has an important role in the formation
of the trabecular and compact myocardium by E11.5.
BrdU and TUNEL assays demonstrate that the deletion of
Mab21l2 causes decreased cell proliferation and
increased apoptosis
The reduced trabecular myocardium and thin compact
myocardium suggest that Mab21l2-deficient embryos have defects
in the regulation of cell proliferation and/or apoptosis in these
regions after E10.5 or E11.5. The proportions of proliferating cells
and apoptotic cells in the heart region were examined using 5-
bromo-29-deoxy-uridine (BrdU) and terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL) assays,
respectively. At E10.5, BrdU incorporation was unchanged
between wild-type and Mab21l2 mutant hearts, suggesting that
the proliferation of myocardial cells was normal (Figure S4). At
E11.5, the BrdU assay showed that the number of cells
incorporating BrdU in the trabecular and compact myocardium
was reduced in Mab21l2 mutant embryos (compact myocardium
of right ventricle, ,20%, and left ventricle, ,20%; WT n=3,
Mab21l2 2/2 n=4; trabecular myocardium of right ventricle,
,5%, and left ventricle, ,6%; Figure 2D–F) compared to wild-
type embryos (Figure 2A–C). BrdU-positive cells were reduced in
the ventricular myocardium lying between the atrium and
ventricle, indicating that Mab21l2-deficient embryos have de-
creased cell proliferation in that region. At E10.5, TUNEL-
positive cells were not generally detected in the heart region of
Mab21l2 mutant embryos (Figure S5D–F). However, in some
Mab21l2 and Septum Transversum Mesenchyme
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e32991Figure 1. Mab21l2 is required for the formation of the trabecular and compact myocardium. (A–F) Whole-mount in situ hybridization of 2-
somite, E8.5 and E9.5 wild-type (WT) embryos for the indicated transcripts. (A, B) At the 2-somite stage, Mab21l2 appeared to be expressed adjacent
to the first heart field expressing Nkx2.5. (C and D) Expression of Mab21l2 was detected in the ventricle, and sinus venosus at E8.5. (E and F) Mab21l2
was expressed in the ventricle (v) and the septum transversum mesenchyme (st) at E9.5. Scale bar represents 60 mm(A, B) and 300 mm (C–E). (G and H)
In situ hybridization analysis of Mab21l2 in transverse paraffin sections of E9.5 WT embryonic heart. (G) Mab21l2 is expressed in the trabecular
myocardium (arrow) and the compact myocardium (arrowhead). (H) Mab21l2 is expressed in the right and left ventricle (black arrowheads). Scale bars
represent 50 mm (G) and 30 mm (H). (I and J) Whole-mount in situ hybridization of E10.5 WT embryos for Mab21l2. (J) Lateral view of the heart shown
in (I). Scale bar in I represents 500 mm. (K and L) In situ hybridization analysis for Mab21l2 in transverse paraffin sections of E10.5 (K) and E11.5 (L) WT
embryonic hearts. (K and L) Expression of Mab21l2 is seen on the left side of the left ventricle (arrowheads). Scale bars represent 50 mm in (K) and
100 mm (L). (M–X) Hematoxylin and eosin (H&E)-stained transverse sections of WT and Mab21l2-mutant embryonic hearts at E11.5 and E12.5. At E11.5,
Mab21l2 mutant embryos show defects in the left ventricle (R), but not in the right ventricle (Q), including reduced trabecular myocardium (arrow)
and thin compact myocardium (arrowheads) compared with WT embryos (N and O). Defects were observed in the right (W) and left (X) ventricle in
Mab21l2 and Septum Transversum Mesenchyme
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the outermost layer of the myocardium in Mab21l2 mutant
embryos (Figure S5G–I). At E11.5, the TUNEL assay showed that
TUNEL-positive cells were not detected in the wild-type embryos
(Figure 2H–J), but were detected in the outermost layer of the
myocardium in Mab21l2-deficient embryos (Figure 2K–M),
suggesting that the deletion of Mab21l2 results in apoptotic cell
death in that region. These results demonstrate that decreased cell
proliferation and increased apoptosis generally occur at around
E11.5 and that defective morphogenesis in the trabecular and
compact myocardium results from dysregulation of cell prolifer-
ation and apoptosis.
The expression of Mab21l2 is required for the
transcription of the gene regulating cell proliferation and
apoptosis
Defects in cell proliferation and apoptosis occurred at around
E11.5. To understand the molecular basis for these defects, we
examined the expression of genes known to regulate these
processes using E11.5 embryo samples. N-myc (Mycn - Mouse
Genome Informatics), which is involved in the regulation of cell
proliferation and apoptosis [25], is expressed in the compact
myocardium between E10.5 and E12.5, and the reduced
expression of N-myc results in the thinning of the compact
myocardium [26,27,28,29,30]. N-myc expression in the compact
myocardium in wild-type and Mab21l2-deficient embryos was
examined at E11.5 using in situ hybridization and quantitative RT-
PCR. N-myc expression in that region was reduced, especially in
the region where cell proliferation was decreased and apoptosis
was increased (37%610% lower) (Figure 2P, Q, R). Decreased
expression of Cyclin D1 (Ccnd1 - Mouse Genome Informatics) [31]
and Id2 [32,33], both N-myc target genes, was also observed in the
heart region (Id2, 53%612% lower; Cyclin D1, 42%67% lower)
(Figure 2R), suggesting that Mab21l2 may regulate cell prolifer-
ation and apoptosis in the compact myocardium through N-myc
expression and via a subset of N-myc target genes, such as Cyclin D1
and Id2.
Nkx2.5 is required for terminal differentiation of cardiomyo-
cytes, including the establishment and/or maintenance of a gene
expression program in the ventricles [34,35,36]. Gata4 is required
for heart tube formation, although Gata4 expression is not essential
for specifying the cardiac cell lineages [34,35,36]. These genes
were normally expressed in Mab21l2 mutant embryos (Figure 2R),
suggesting that the deletion of Mab21l2 does not affect cardiac
specification and heart tube formation. In Mab21l2-mutant hearts,
the expression of differentiation marker genes was decreased, such
as the molecular marker for chamber myocardium, Chisel (Smpx -
Mouse Genome Informatics) [37], and an early myocardial
differentiation marker, Mlc2v (Myl2 - Mouse Genome Informatics)
(Chisel, 56%69% lower; Mlc2v, 49%613% lower) (Chisel,
Figure 2R, Figure S6C, D; Mlc2v, Figure 2R, Figure S6G, H).
However, if defects in myocardial differentiation occur, defects in
heart development would also occur at much earlier stages.
Therefore, decreased expression of myocardial differentiation
markers is a secondary effect of decreased cell proliferation. Erbb2
and Erbb4 are expressed in the myocardium, and the signaling
pathway activated through the ligand NRG1 and the ERBB2/
ERBB4 receptor is essential for the development of the trabecular
myocardium [38,39,40]. The expression of Erbb2 was unchanged
in Mab21l2-deficient embryos (Figure 2R), but that of Erbb4 was
reduced in the ventricle of Mab21l2-deficient embryos (73%68%
lower levels; Figure 2R, Figure S6K, L), although this difference
could not be statistically confirmed. Bmp10 is expressed after
E8.75, and, by E11.5, the expression of Bmp10 is detected
primarily in the trabecular region. Bmp10 is required for
promoting proliferative activity in myocardial cells through
transcriptional regulation of P57 (Cdkn1c - Mouse Genome
Informatics) [41], which is an important negative regulator
involved in cell cycle exit [42], as well as maintenance of the
expression of several important cardiogenic factors, such as Nkx2.5
and Mef2c [41]. However, the expression of Bmp10 and P57 was
not altered in Mab21l2 mutant embryos at E11.5 (Figure 2R). The
endocardial expression of Flk1 (Kdr - Mouse Genome Informatics),
Tie1, and Tie2 (Tek - Mouse Genome Informatics) is required for
trabeculation [43,44,45,46]. The expression of these genes was
unchanged in Mab21l2 mutants (Figure 2R), suggesting that
defective morphogenesis of the trabecular myocardium does not
result from defects in endocardial development. These results
suggest that reduced expression of Erbb4 has an effect on
trabecular development.
Mab21l2 is expressed in the proepicardium and plays a
crucial role in the formation of this region and of the
epicardium
Next, it was examined whether defects occurred in the
formation of the tissue adjacent to the ventricular myocardium:
the endocardium, which lines the inside of the heart, and the
epicardium, which covers the outside. The endocardium is formed
in precardiac mesoderm [47,48,49], and signaling from the
endocardium to the ventricular myocardium is required to initiate
the conversion of the myocardial layer of the primitive heart tube
into a thickened myocardial wall capable of contraction. The
epicardium is formed after E10.5 and is required for optimal
myocardial cell proliferation, leading to the formation of the
normally contracting myocardium. Mab21l2 expression was not
detected in the endocardium or epicardium between E9.5–E12.5
(Figure S1A, B, S2A, B). Mab21l2 was expressed in the
proepicardium at E9.5 (Figure 1E, F, 3A, B). To study the effect
of Mab21l2 expression on proepicardium formation, we examined
whether the proepicardium was normally formed in Mab21l2
mutant embryos. H&E staining showed defective morphogenesis
of the proepicardium (Figure 3D). Next, the expression of
proepicardial and epicardial marker genes, such as Wt1 [50],
and Tbx18 [51] in Mab21l2-deficient embryos was examined. The
proepicardium (Tbx18
+, Wt1
+ region) was significantly small in
Mab21l2 mutants (Tbx18, Figure 3F; Wt1, Figure 3H), demon-
strating that defects in proepicardium formation occurred in
Mab21l2 mutant embryos. These results suggest that Mab21l2
plays a critical role in the formation of the proepicardium.
The defective morphogenesis of the proepicardium could result
in defects in the epicardium. H&E staining of heart sections of
Mab21l2-deficient embryos suggested that the epicardium was not
formed (Figure 3K, L). To confirm the absence of the epicardium,
the expression of Tbx18 and Wt1 was examined in Mab21l2
mutant embryos. The expression was not detected around the
heart (Tbx18, Figure 3O, P; Wt1, Figure 3S, T), demonstrating
Mab21l2-mutants compared with WT embryos at E12.5 (T and U) (compact myocardium, arrowheads; trabecular myocardium, arrows). a, atrium; cac,
common atrium chamber; cvc, common ventricular chamber; ot, outflow tract; g, ventricular groove; la, left atrium; lv, left ventricle; ra, right atrium;
rv, right ventricle; v, ventricle; s, interventricular septum; st, septum transversum mesenchyme; sv, sinus venosus. Scale bar represents 100 mm (M, P, S
and V).
doi:10.1371/journal.pone.0032991.g001
Mab21l2 and Septum Transversum Mesenchyme
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e32991Figure 2. Decreased proliferation and increased apoptosis in Mab21l2 mutant embryos. (A–F) BrdU assay on transverse paraffin sections of
E11.5 WT and Mab21l2 mutant (2/2) embryos. BrdU staining shows decreased cell proliferation in the trabecular myocardium and compact
myocardium (asterisk) of left (F) and right ventricle (E) in Mab21l2 mutant (D–F) compared to WT embryos (A–C). (G) Quantification of BrdU
incorporation. The percentage of BrdU-positive myocardial cells was calculated by dividing the number of BrdU-positive myocardial cells by that of
total myocardial cells identified by hematoxylin staining. The values show means of the proportions of BrdU-positive nuclei. Error bars represent the
standard deviation and p values were calculated using the two-tailed Student’s t test. (H–M) TUNEL assay in transverse paraffin sections of E11.5
embryos. Increased apoptosis is seen in Mab21l2 mutant embryonic hearts (K–M) compared to WT (H–J). Arrowheads indicate TUNEL-positive cells
(red). (N–Q) In situ hybridizations on transverse paraffin sections of E11.5 WT and Mab21l2 mutant embryonic hearts for N-myc. N-myc expression was
reduced in the compact myocardium of Mab21l2 mutants (P and Q) compared to WT embryos (N and O), especially in the dorsal region of the left
ventricle (arrowheads). la, left atrium; lv, left ventricle; ra, right atrium; rv, right ventricle. Scale bars represent 100 mm (A, D, H, K) and 50 mm (N and P).
(R) Quantitative RT-PCR for genes regulating cell proliferation and apoptosis (N-myc, Id2, Cyclin D1, Cyclin D2), marker genes of myocardial
differentiation (Anf, Chisel, Mlc2v), genes essential for the development of the trabecular myocardium (Erbb2, Erbb4, Bmp10), genes essential for heart
development (Nkx2.5, Gata4), and endocardial transcripts (Flk1, Tie1, Tie2) normalized to Gapdh expression using RNA from dissected hearts of E11.5
WT and Mab21l2 mutant (2/2) embryos. Error bars represent standard deviation of the mean (WT, n=3; Mab21l2 (2/2), n=3). P values were
calculated using the unpaired two-tailed Student’s t test.
doi:10.1371/journal.pone.0032991.g002
Mab21l2 and Septum Transversum Mesenchyme
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that Mab21l2 contributes to the formation of the epicardium
through the formation of the proepicardium.
Defective morphogenesis of the epicardium results from
reduced expression of a4 integrin and decreased cell
proliferation in the small proepicardium
In E9.5 Mab21l2 mutant embryos, the small proepicardium is
present, but the epicardium is not formed by E11.5. Among
mutants that have defects in epicardium formation, a4 integrin
(Itga4 - Mouse Genome Informatics) and Vcam-1 (Vascular cell
adhesion molecule-1) mutants have been previously reported
[52,53,54]. a4 integrin encodes the a4 subunit of a4b1 integrin, a
cell adhesion receptor, which binds to fibronectin [55,56] and
VCAM-1 [57,58]. a4 integrin is expressed in the proepicardium and
Vcam-1 is expressed in the myocardium. In a4 integrin and Vcam-1
mutant embryos, the proepicardium is normally formed by E9.5,
and by E10.5, the epicardium is also normally formed in a4 integrin
mutant embryos, however, by E11.5 the epicardium is absent from
both mutant embryos [52,54], demonstrating that the interaction
through a4 integrin and Vcam-1 is required for maintenance of cell
adhesion of epicardial cells that have migrated to the surface of the
heart. In another a4 integrin mutant line, epicardium formation did
not occur by E10.5, suggesting that a4 integrin is also required for
proepicardial cell migration from the proepicardium to the surface
of the heart, and particularly for proepicardial cell adhesion to the
myocardium when proepicardial cells reach this tissue [53]. In the
remaining proepicardium and the myocardium, the expression of
a4 integrin and Vcam-1 was examined. The expression of Vcam-1 in
Figure 3. Mab21l2 is required for the formation of the proepicardium and the epicardium. (A,B, E–H, M–T) In situ hybridizations of sagital
(A, B, E–H) and transverse (M–T) paraffin sections of E9.5 and E11.5 WT and Mab21l2 mutant embryos for the transcripts indicated. (C, D, I–L) H&E-
stained transverse sections of E9.5 and E11.5 WT and Mab21l2 mutant embryos. Mab21l2 expression was detected in the proepicardium (arrowhead)
of E9.5 WT embryos (A and B). Compared to WT embryos (C), the proepicardium (arrowhead) was absent in Mab21l2 mutant embryos (D). Expression
of the proepicardial and epicardial marker genes, Tbx18, and Wt1, was compared between WT ([E] Tbx18; [G] Wt1), and Mab21l2 mutant embryos ([F]
Tbx18; [H] Wt1), showing that the proepicardium is significantly small in Mab21l2 mutant embryos. In E11.5 WT embryos (I and J), the epicardium
(arrowhead) occurs between the compact myocardium and the body wall (arrows), but in Mab21l2 mutant embryos (K and L), the epicardium is
absent. The expression of epicardial marker genes was detected in E11.5 WT epicardium ([M and N] Tbx18; [Q and R] Wt1), arrowheads), but not in
Mab21l2 mutant embryos ([O and P] Tbx18; [S and T] Wt1), between the compact myocardium and the body wall (arrows). a, atrium; v, ventricle; la,
left atrium; lv, left ventricle; ra, right atrium; rv, right ventricle; sv, sinus venosus. Scale bars represent 30 mm (C and D), 50 mm (A, E–H), and 100 mm (I,
K, M, O, Q and S).
doi:10.1371/journal.pone.0032991.g003
Mab21l2 and Septum Transversum Mesenchyme
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e32991the myocardium was unchanged (Figure S7A, B), but that of a4
integrin was significantly reduced in the remaining proepicardium
(Wt1
+ region) (Wt1, Figure 4C, D; a4 integrin, Figure 4G, H). To
confirm that the epicardium was absent at E10.5, the expression of
Tbx18, and Wt1 was examined in Mab21l2 mutant embryos.
Expression was not detected around the heart (Tbx18, Figure S8C,
D; Wt1, Figure S8G, H), suggesting that the epicardium is not
formed at E10.5. These results suggest that reduced expression of
a4 integrin in the remaining proepicardium results in defects of the
migration of proepicardial cells, leading to defective morphogen-
esis of the epicardium by E10.5. Next, cell proliferation and
apoptosis in the remaining proepicardium were examined using
BrdU and TUNEL assays, respectively. The number of cells
incorporating BrdU in the remaining proepicardium expressing
Tbx18 was lower in Mab21l2 mutant embryos (,16%; WT n=3,
Mab21l2 2/2 n=3; Figure 4L, M) than in wild-type embryos
(Figure 4J, M). However, TUNEL-positive cells were not detected
in the remaining proepicardium (data not shown). Taken together,
the results suggest that defective morphogenesis of the proepi-
cardium results from dysregulation of cell proliferation in
proepicardial cells.
Mab21l2 is expressed in the septum transversum
mesenchyme near hepatoblasts and plays an essential
role in the formation of the liver
Next, we examined whether Mab21l2 was expressed, not only in
the proepicardium, at the anterior of the STM, but also in the rest
of the STM. At E8.5, the expression of Mab21l2 was detected in
the STM and sinus venosus myocardium (Figure 5A). At E9.5, the
STM surrounds the hepatoblasts; therefore, Mab21l2 expression
was examined in this region (STM marker: Gata4), and in the
Figure 4. In the remaining proepicardium, a4 integrin expression and cell proliferation are reduced. (A–H, I and K) In situ hybridizations
of sagital paraffin serial sections of E9.5 WT and Mab21l2 mutant embryos for the transcripts indicated. In WT embryos, a4 integrin (F) was expressed
in Wt1-positive proepicardial cells (B). In Mab21l2-mutant embryos, the expression of a4 integrin (H; black arrowhead) was significantly reduced in the
Wt1-positive proepicardial cells (D). (J and L) BrdU assay on sagital paraffin serial sections of E9.5 from the WT and Mab21l2 mutant (2/2) embryos.
BrdU staining shows decreased cell proliferation in the Tbx18-positive proepicardial cells in the Mab21l2 mutant (L; red arrowhead) compared to WT
embryos (J). (M) Quantification of BrdU incorporation. The percentage of BrdU-positive proepicardial cells was calculated by dividing the number of
BrdU-positive proepicardial cells by that of the total proepicardial cells identified by Tbx18 expression. The values show means of the proportions of
BrdU-positive nuclei. Error bars represent the standard deviation and p values were calculated using the two-tailed Student’s t test. a, atrium; v,
ventricle; sv, sinus venosus. Scale bars represent 50 mm (A, C, E, G) and 30 mm (I–L).
doi:10.1371/journal.pone.0032991.g004
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Mab21l2 expression (Figure 5B; Figure 3A, B) overlapped almost
completely with Gata4 expression (Figure 5C), but not with Prox1
(Figure 5D), showing that Mab21l2 is expressed in the caudal
region of the STM, but not in hepatoblasts. The expression of
Mab21l1 was not expressed in the STM.
To study the effect of Mab21l2 expression on the formation of the
caudal region of the STM, H&E-stained sections of Mab21l2-
Figure 5. Mab21l2 is required for the formation of the septum transversum mesenchyme near hepatoblasts and for normal liver
development. (A–D, G, H, M–P) In situ hybridizations of transverse paraffin sections of E8.5, E9.5 and E10.5 WT and Mab21l2 mutant embryos, for the
transcripts indicated. (Q and S) In situ hybridizations of sagital paraffin sections of E9.5 WT and Mab21l2 mutant embryos for Hhex. (E, F, and I–L) H&E-
stained transverse sections of E9.5, E10.5, and E11.5 WT and Mab21l2 mutant embryos. (R and T) BrdU assay on sagital paraffin serial sections of E9.5
from the WT and Mab21l2 mutant (2/2) embryos. (U) Quantification of BrdU incorporation. The percentage of BrdU-positive hepatic cells was
calculated by dividing the number of BrdU-positive hepatic cells by that of the total hepatic cells identified according to Hhex expression. The values
show means of the proportions of BrdU-positive nuclei. Error bars represent the standard deviation and p values were calculated using the two-tailed
Student’s t test. Mab21l2 expression was detected in the STM at E8.5 (A). Comparing the expression of Mab21l2 (B), Gata4, an STM marker (C) and
Prox1, a hepatoblast marker (D) in E9.5 WT embryos indicated that Mab21l2 is expressed in the STM (arrowheads) near hepatoblasts (arrows) at E9.5.
Defective morphogenesis was observed in the region near the liver bud in E9.5 Mab21l2 mutant (F) compared to WT embryos (E). Gata4 was not
expressed in this region (G) but Prox1 was expressed (H). Mab21l2 mutant embryos at E10.5 (J) and E11.5 (L) show defective morphogenesis of the
liver (arrowheads) compared to WT embryos (I and K). At E10.5, the expression of Hnf4a (hepatoblast marker) and Flk1 (endothelial marker) was
detected in Mab21l2 mutant embryos (O and P). BrdU staining shows decreased cell proliferation in the Hhex-positive hepatic region in the Mab21l2
mutant (T) compared to WT embryos (R). lb, liver bud; st, septum transversum mesenchyme; sv, sinus venosus. Scale bar represents 30 mm (A–H, Q–T),
50 mm (I, J, M–P) and 100 mm (K, L).
doi:10.1371/journal.pone.0032991.g005
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emergence of the liver bud occurred normally, although defective
morphogenesis was observed around the liver bud (Figure 5F);
however, the region from which the defects originated was unclear.
To test whether these defects occurred in the STM or in
hepatoblasts, the expression of Gata4 and Prox1 was examined in
Mab21l2 mutant embryos. Prox1 expression was detected in
hepatoblasts (Figure 5H), but Gata4 was not (Figure 5G). Besides,
Tbx18
+, Wt1
+ cells (proepicardial cells) were detected in Mab21l2
mutant embryos at E9.5, but Tbx18
2, Wt1
+ cells (STM cells except
proepicardial cells) were not (Tbx18, Figure 3F; Wt1, Figure 3H).
These resultsshowthattheSTMwasabsentfromtheregionaround
thehepatoblastsatE9.5.TheseresultssuggestthatMab21l2playsan
essential role in the formation not only of the proepicardium (the
STM caudal to the heart), but also of the rest of the STM.
The caudal region of the STM functions as a source of signals
for hepatoblast growth and survival, and the inactivation of genes
encoding these signaling molecules causes liver hypoplasia [5], and
therefore, defects in the STM would be expected to cause
dysmorphogenesis of the liver. H&E-stained sections of Mab21l2
mutant embryos at E10.5 and E11.5 suggested that defective
morphogenesis of the liver had occurred (Figure 5J, L). To verify
whether the remaining tissue was hepatic tissue, the expression of
Hnf4a (hepatoblast marker) and Flk1 (endothelial cell marker) was
examined. The expression of both genes was detected in Mab21l2
mutant embryos (Figure 5O, P), showing that hepatoblasts,
surrounded by endothelial cells, were present in the small liver
of Mab21l2 mutant embryos. Next, BrdU and TUNEL assays were
performed to examine whether decreased cell proliferation and/or
increased apoptosis, respectively, occurred in the hepatic region.
The number of cells incorporating BrdU in the hepatic region
expressing Hhex was lower in Mab21l2 mutant embryos (,24%;
WT n=3, Mab21l2 2/2 n=3; Figure 5T, U) than in wild-type
embryos (,37%; Figure 5R, U). However, no TUNEL-positive
cells were detected in the hepatic region (data not shown). Taken
together, the results suggest that defective STM morphogenesis
results in a decrease in the signals promoting hepatoblast
proliferation, leading to a small liver. Next, the expression of the
endothelial marker, Flk1, and the hepatoblast markers, Alb, Hhex,
and Hnf4a was examined in wild-type and mutant embryos. The
expression of Flk1 was unchanged in Mab21l2 mutant embryos
(Figure S9E), suggesting that the loss of the basement membrane
occurred as normal. The expression of Alb, Hhex and Hnf4a was
also unchanged (Figure S9F, H) suggesting that the initial hepatic
induction occurred as normal and that defective morphogenesis of
the STM does not affect hepatoblast differentiation at E9.5.
Discussion
This study demonstrated that Mab21l2 is expressed in the
septum transversum mesenchyme (STM) including the proepicar-
dium, and plays an essential role in the formation of that tissue.
The STM is derived from the lateral-plate mesoderm. At E7.5, the
presumptive STM is located at the junction between the visceral
yolk sac and the amnion. This positional relationship is maintained
during neural fold formation and foregut invagination, and, as a
result, at E9.0 the STM is located caudal to the heart. Currently,
Gata4 is known to be essential for the formation of the
proepicardium [59], and the phenotype of Gata4 mutant embryos
in proepicardium formation is the same as Mab21l2 mutant
embryos. However, the precise molecular mechanisms underlying
the formation of the proepicardium remain unknown.
From the anterior surface of the STM, the proepicardium,
epicardial progenitor cells migrate to the heart to form the
epicardium. In the remaining proepicardium of Mab21l2 mutant
embryos, cell proliferation was decreased, suggesting that Mab21l2
contributes to proepicardium formation by promoting the prolifer-
ation of proepicardial cells. Although a small proepicardium was
present in Mab21l2 mutant embryos, not even transient epicardial
formation was observed at E9.5–E10.5, suggesting that defects also
occur in the migration of proepicardial cells from the proepicardium
to the heart surface in Mab21l2 mutant embryos. Vcam-1 was
normally expressed in the myocardium, but the expression of a4
integrin was significantly reduced in the remaining proepicardium
(Wt1
+region).a4in te gr inisessential forthe migration ofproepicardial
cells onto the heart surface, suggesting that, in Mab21l2 mutant
embryos, proepicardial cells that reach the heart surface cannot
adhere to the myocardium due to reduced expression of a4-integrin.
Thus, during epicardial development,Mab21l2 plays important roles
in both proepicardium formation and proepicardial cell migration.
Epicardial cells play a crucial role during heart development by
providing a source of cells contributing to heart formation, such as
cardiac fibroblasts, pericytes and smooth muscle cells [8,9,10,11].
Although beginning to invade the myocardium at E11.5 [60],
epicardial cells provide signaling molecules promoting the prolifer-
ationofthemyocardialcells[12,13].Cellproliferationwasdecreased
in E11.5 Mab21l2-mutant embryonic hearts, suggesting that
myocardial defects and loss of the epicardium affect cardiomyocyte
proliferation. Mice mutant in Wt1, a4integrin or Vcam-1 has defects in
epicardium formation, resulting in defects in heart development
similar to Mab21l2 mutant embryos, further demonstrating the
importance of the epicardium for normal heart development. Taken
together, these results suggest that Mab21l2 plays an essential role
during heart development through the formation of the proepicar-
dium and the epicardium.
Embryonic lethality in Mab21l2 mutant embryos occurred after
E11.5, and the expression of Mab21l2 was detected especially in
the left ventricle at E10.5 and E11.5. In E11.5 Mab21l2 mutant
embryos, defective morphogenesis was observed not only in the
left ventricle, but also in the epicardium. Epicardial cells,
surrounding the right and left ventricle, promote cell proliferation
of surrounding cardiomyocytes, and it is possible that defects in the
epicardium have an effect on cardiomyocyte cell proliferation. If
loss of the epicardium has a major influence on defects in the
myocardium, these defects would be expected to occur in the right
and left ventricle. However, defects were observed only in the left
ventricle, suggesting that defective morphogenesis in the left
ventricle at E11.5 largely results from loss of function of Mab21l2
in the myocardium. At E12.5, defects in the heart region were
observed in the right and left ventricle. At E11.5 and E12.5, the
expression of Mab21l2 was not detected in the right ventricle,
suggesting that defects in the heart region at E12.5 largely result
from loss of the epicardium. The trabecular and compact
myocardium are essential for maintaining adequate blood
circulation, suggesting that embryonic lethality observed in
Mab21l2 mutants at approximately E11.5 may be caused by
defective morphogenesis of these regions.
The STM is important not only as a source of progenitors of the
epicardium, but also as a source of various signaling components.
Prior to and during hepatic induction, inductive signals such as
BMPs are expressed in the STM and initiate the liver gene
program in the proximal endoderm in conjunction with FGFs
from the cardiac mesoderm. In Mab21l2 mutant embryos, marker
genes of hepatic induction, such as Alb, Hhex, are normally
expressed in the hepatic tissue at E9.5, suggesting that the
induction of the liver gene program may normally occur, and at
the stage when hepatic induction occurs, the STM may be present.
After the induction of liver development, the STM near
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regulating the growth and survival of hepatoblasts (reviewed in
[4,5]). Reduced cell proliferation was observed in the hepatic
region in Mab21l2 mutant embryos at E9.5. Flk1 expression in
Mab21l2 mutant embryos suggests that the endothelial basement
membrane degrades as expected, and Prox1, which is required for
the migration of hepatoblasts into the STM from the liver bud
[61], was expressed normally in hepatoblasts in Mab21l2 mutant
embryos (Figure 5H), suggesting that hepatoblasts may be
clustered in the liver bud in these embryos, because the STM
into which hepatoblasts migrate was absent. Other hepatoblast
markers, such as Alb, Hhex and Hnf4a, were expressed normally,
suggesting that defective morphogenesis of the STM does not
affect hepatoblast differentiation at E9.5. Thus, defective liver
morphogenesis in Mab21l2 mutant embryos was caused by loss of
the signals from the STM that are required for hepatoblast
growth. Taken together, these results show that Mab21l2 plays an
essential role in liver morphogenesis by mediating the formation of
the STM. Mab21l2 is expressed in the STM, not in surrounding
hepatoblasts. Loss of function of Mab21l2 results in defective
morphogenesis of the STM, leading to defects in cell proliferation
of hepatoblasts. These results suggest that Mab21l2 has effects on
liver development in a non-cell-autonomous manner.
The STM is a transient tissue that exists during embryogenesis
from around E7.5 to E9.5, and is adjacent to the various organs or
presumptive organ regions, such as the heart, liver and ventral
pancreas. Similar to Mab21l2-deficient mice, Gata4-deficient mice
lack the STM, including the proepicardium, at E9.5, but Gata4
mutant mice die by approximately E10.0, and therefore the
importance of the STM as a tissue during organogenesis after E10.5
has remained unknown [59,62]. Fortunately, Mab21l2 mutant mice
survive after E10.5, allowing the contribution of the STM to
organogenesis after E10.5 to be examined. In this study, we have
shown that defects of the STM, including the proepicardium,
resulted in the loss of the epicardium and defective morphogenesis
of the heartand liver. These resultsdemonstrate that the STM plays
essential roles in the morphogenesis of the surrounding organs, such
as the heart and liver, although the molecular functions of the
MAB21L2 protein remain unclear. To uncover the molecular
mechanism underlying STM morphogenesis, it will be necessary to
analyze MAB21L2 protein function, which should help to provide a
detailed understanding of how the STM functions during the
morphogenesis of its surrounding organs.
Materials and Methods
Mice
The generation of mutant mice has been reported previously
[22]. Mice were maintained in accordance with protocols
approved by the Animal Care and Use Committee of the
University of Tokyo.
In situ hybridization
Whole-mount in situ hybridization was performed as described
previously [63] at 65uC in 50% formamide containing 56 SSC.
Paraffin sections were hybridized in situ at 65uC in 50% formamide,
20 mM Tris-HCl (pH 8.0), 300 mM NaCl, 0.2% Sarkosyl, 16
Denhart’s solution, 10% dextran sulfate, and 0.5 mg/ml yeast
tRNA. All probes were labeled with digoxigenin using standard
procedures. Details for probes will be provided upon request.
Histology
Embryos were dissected in phosphate-buffered saline (PBS) and
fixed in 4% paraformaldehyde in PBS overnight at 4uC. The fixed
embryos were dehydrated through a graded alcohol series and
embedded in paraffin, sectioned (8 mm thick sections), and stained
with hematoxylin and eosin.
Detection of proliferating or apoptotic cells
Pregnant mice were injected intraperitoneally with 3 mg
bromodexyuridine (BrdU). Embyros were sacrificed 2 h later
and fixed in 4% paraformaldehyde in PBS overnight at 4uC.
Sections (8 mm thick) of embryos embedded in paraffin were
stained with an anti-BrdU antibody using the BrdU Labeling and
Detection Kit II (Roche). TdT-mediated dUTP nick end labeling
(TUNEL) analysis was performed as follows. Sections (8 mm thick)
of embryos embedded in paraffin were incubated in 3% H2O2 for
15 min, ProK solution for 10 min, and then incubated in TdT
reaction solution (0.2 mM fluorescein-12-dUTP (Roche), 0.2 mM
dATP, 1 mM CoCl2, 30 mM Tris-HCl (pH 7.5), 140 mM sodium
cacodylate, 40 U terminal deoxynucleotidyl transferase (Roche)).
Fluorescein was detected with an alkaline phosphatase-conjugated
anti-fluorescein antibody (Roche) in a solution containing a
phosphatase substrate (Fast Red Tablets, Roche), and counter-
stained with hematoxylin.
Quantitative RT-PCR
Whole hearts were dissected from E11.5 embryos. The hearts
were disrupted in Sepasol(R)-RNA II Super (Nacalai Tesque) and
RNA was purified using standard methods. Synthesis of cDNAs
was performed with 150 ng total RNA using M-MuLV Reverse
Transcriptase (BioLabs). Quantitative real-time PCR was per-
formed using the SYBR Premix Ex TaqTM (Takara Bio), on a
Thermal Cycler Dice Real Time System TP800 (Takara Bio),
according to the manufacturer’s protocols. All results were
normalized to the levels of glyceraldehyde-3-phosphate dehydro-
genase (Gapdh) mRNA. The primers used in this study were as
follows: Anf-Fw, TGTACAGTGCGGTGTCCAAC; Anf-Rv, CC-
TGCTTCCTCAGTCTGCTC; Bmp10-Fw, CTGAACTGCGG-
TTGTACACG; Bmp10-Rv, CTCCTCTCCTCCTCGCTACC;
Chisel-Fw, CACCGGGAGTTCCTTCTATC; Chisel-Rv, TAGC-
CCTGCTCTCTGGATTG; Cyclin D1-Fw, GGGACATAGCAT-
CACAGCAG; Cyclin D1-Rv, CCGGAGACTCAGAGCAAATC;
Cyclin D2-Fw, ACCGCACACATAGGCTTCTC; Cyclin D2-Rv,
ATAACACCTCCTGGGGCTTC; Erbb2-Fw, TCAGCCCCA-
GAGGATTACAG; Erbb2-Rv, CTGCTCCCAGGATATTCA-
CC; Erbb4-Fw, AACAGCAGTACCGAGCCTTG; Erbb4-Rv,
GGATAGACCGCAGGAAGGAG; Flk1-Fw, GGCCGAGTC-
TGTCTACCTTG; Flk1-Rv, CTTCCTTCCTCCCAGTCCAC;
Gata4-Fw, TCTCACTATGGGCACAGCAG; Gata4-Rv, CAGA-
CAGCACTGGATGGATG; Id2-Fw, CCCCAGAACAAGAA-
GGTGAC; Id2-Rv, ATGCAGGCTGACGATAGTGG; Mlc2v-
Fw, TACCCACGGAGAAGAGAAGG; Mlc2v-Rv, CCAGAGC-
CAAGACTTCCTGT; Nkx2.5-Fw, TTGACGTAGCCTGGT-
GTCTC; Nkx2.5-Rv, CCCGGTCCTAGTGTGGAATC; N-myc-
Fw, AATTGGTCCCCTGTCGAGTC; N-myc-Rv, CACCCAG-
CATCCCATAAGTC; P57-Fw, GGACGATGGAAGAACTC-
TGG; P57-Rv, AAAACCGTGGGCTGCTCTAC; Tie1-Fw, CT-
GCGATGACGAAGTGTACG; Tie1-Rv, CCCAACTGTAGT-
GCGATCTG; Tie2-Fw, ACCCACTGCCAAGAGATGTG; Tie2-
Rv, AGATCCGCACGAGCTGTATG.
Supporting Information
Figure S1 Mab21l2 is expressed in the myocardium. (A–
D) In situ hybridizations of Mab21l2 (A and B) and Nkx2.5 (C and
D) in transverse serial paraffin sections of WT embryonic hearts at
E9.5. Expression of Mab21l2 was detected in the trabecular and
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ocytes). en, endocardium; ot, outflow tract; v, ventricle; t,
trabecular myocardium; c, compact myocardium. Scale bar
represents 50 mm.
(TIF)
Figure S2 The expression of Mab21l2 at E12.5. (A and B)
In situ hybridizations of transverse paraffin sections of E12.5 WT
embryonic hearts for Mab21l2. Mab21l2 expression was detected at
low levels in the trabecular myocardium (arrow), not in the
epicardium (arrowhead) at E12.5 (A and B). la, left atrium; lv, left
ventricle; ra, right atrium; rv, right ventricle. Scale bar represents
100 mm (A).
(TIF)
Figure S3 Defective morphogenesis in the heart region
is observed from E10.5. (A–J) H&E-stained transverse sections
of E8.5, E9.5 and E10.5 WT and Mab21l2 mutant embryonic
hearts. Defects in the heart region were not observed in Mab21l2
mutant embryos (B, D and F) compared to WT embryos (A, C and
E) at E8.5 (A and B) and E9.5 (C–F). However, thin compact
myocardium was just visible in some Mab21l2 mutant (H and J)
compared to WT embryos (G and I) at E10.5 (G–J). cvc, common
ventricular chamber; la, left atrium; lv, left ventricle; ot, outflow
tract; ra, right atrium; rv, right ventricle. arrows, trabecular
myocardium; arrowheads, compact myocardium. Scale bar
represents 30 mm (A and B), and 50 mm (C, D, G and H).
(TIF)
Figure S4 At E10.5, cell proliferation in the heart region
of the Mab21l2-mutant is unchanged compared to that of
WT embryos. (A–F) BrdU assay on transverse paraffin sections
of E10.5 WT and Mab21l2 mutant (2/2) embryos. BrdU staining
shows that cell proliferation in the heart region of the Mab21l2-
mutant (D–F) is normal, compared to WT embryos (A–C). (G)
Quantification of BrdU incorporation. The percentage of BrdU-
positive myocardial cells was calculated by dividing the number of
BrdU-positive myocardial cells by that of the total myocardial cells
identified by hematoxylin staining. The values show means of the
proportions of BrdU-positive nuclei. Error bars represent the
standard deviation. la, left atrium; lv, left ventricle; ra, right
atrium; rv, right ventricle. Scale bar represents 50 mm.
(TIF)
Figure S5 At E10.5, apoptosis in the heart region is
generally unchanged in Mab21l2-mutant compared to
WT embryos. (A–I) TUNEL assay on transverse paraffin
sections of E10.5 embryos. (D–F) In Mab21l2 –mutant embryos
(D–F), apoptosis was not generally detected in the heart region,
but in some Mab21l2-mutant embryos (G–I), increased apoptosis
was observed. Arrowhead indicates TUNEL-positive cells (red). lv,
left ventricle; ra, right atrium; rv, right ventricle. Scale bar
represents 50 mm.
(TIF)
Figure S6 Mab21l2 mutants show defective expression
of some myocardial differentiation markers and of
Erbb4 essential for ventricular trabeculation. (A–L) In situ
hybridizations of transverse paraffin sections of E11.5 WT and
Mab21l2 mutant embryonic hearts for the transcripts indicated.
The expression of Chisel and Mlc2v (cardiomyocyte differentiation
markers), was reduced in the myocardium of Mab21l2 mutants
(Chisel [C and D]; Mlc2v [G and H]; arrowheads) compared to WT
embryos (Chisel [A and B]; Mlc2v [E and F]), especially in the
dorsal region of the left ventricle (arrowheads). The expression of
Erbb4 (essential for trabecular myocardial development in the
heart ventricle) was also reduced in the Mab21l2 mutant
myocardium (K and L) compared to WT embryos (I and J). la,
left atrium; lv, left ventricle; ra, right atrium; rv, right ventricle.
Scale bar represents 50 mm.
(TIF)
Figure S7 Vcam-1 expression was unchanged in
Mab21l2-mutant myocardium. (A and B) In situ hybridization
analysis of Vcam-1 in sagital paraffin sections of E9.5 WT and
Mab21l2 mutant embryos. (B) Vcam-1 was normally expressed in
the Mab21l2-mutant embryo myocardium compared with WT
embryos (A). a, atrium; v, ventricle; sv, sinus venosus. Scale bars
represent 50 mm.
(TIF)
Figure S8 Defective morphogenesis of the epicardium
occurred by E10.5. (A–H) In situ hybridizations of transverse
paraffin sections of E10.5 WT and Mab21l2 mutant embryos for
the transcripts indicated. The expression of epicardial marker
genes was detected in E10.5 WT epicardium ([A and B] Tbx18;[ E
and F] Wt1), arrowheads), but not in Mab21l2 mutant embryos ([C
and D] Tbx18; [G and H] Wt1) between the compact myocardium
and the body wall (arrows). lv, left ventricle; ra, right atrium; rv,
right ventricle. Scale bar represents 50 mm.
(TIF)
Figure S9 Defective morphogenesis of the STM does not
affect the expression of the endothelial marker, Flk1,o r
the hepatoblast markers, Alb, Hhex and Hnf4a. (A–H) In
situ hybridization of transverse paraffin sections of E9.5 WT and
Mab21l2 mutant embryos for the transcripts indicated. Flk1
expression was not altered in Mab21l2 mutant embryos (E),
compared to WT embryos (A). The expression of the hepatoblast
markers, Alb, Hhex and Hnf4a also remained unaltered in Mab21l2
mutant embryos (F–H), compared to WT embryos (B–D). lb, liver
bud; arrowheads, septum transversum mesenchyme. Scale bar
represents 30 mm.
(TIF)
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